Viewing nowM-Shoobet 25 mg (Empagliflozin 2L-Proline)
Empagliflozin 2L-Proline 37.766mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 202502438 · Approved 2025.09.15
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes. It is administered as an adjunct to diet and exercise and can be used as monotherapy or in combination with other medications. It is particularly effective in patients whose blood sugar is not adequately controlled. Additionally, it is recommended for safe use based on clinical trial information regarding the occurrence of cardiovascular events in patients with type 2 diabetes accompanied by cardiovascular disease. This medication helps improve patients' health by aiding diabetes management through blood sugar control.
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this medicine in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected in these patients. •Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in these patients. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, section 4. General Precautions).
This medication should not be administered to specific patients. First, patients who are allergic to the main ingredient or components of this medication should not take it. Patients with type 1 diabetes or diabetic ketoacidosis may also be at risk if they use this medication. Furthermore, patients with lactose intolerance or genetic galactose metabolism disorders should not take this medication due to the lactose it contains. Patients with impaired kidney function should use this medication cautiously. In particular, in patients with significantly reduced kidney function, the effectiveness of this medication may diminish, or the risk of side effects may increase; thus, regular kidney function testing is required. Patients with chronic heart failure or chronic kidney disease should also consult their doctor sufficiently before using this medication. The risk of hypoglycemia may increase when this medication is used in conjunction with blood sugar-lowering medications such as insulin or sulfonylureas; therefore, dosage adjustments may be necessary when combined with such medications. Major side effects that may occur while taking this medication include hypoglycemia, genital infections, urinary tract infections, increased urination, decreased fluid volume, liver function abnormalities, etc. Hypoglycemia, in particular, may occur more frequently when taken with insulin or sulfonylureas, so caution is advised. Serious metabolic disorders such as ketoacidosis may rarely occur in association with this medication; thus, if symptoms such as nausea, vomiting, abdominal pain, or difficulty in breathing appear, it is essential to inform medical personnel immediately. Additionally, elderly patients or those with cardiovascular disease who are at risk of fluid loss or low blood pressure should closely monitor their fluid status while taking this medication. This medication may impact liver function; therefore, patients with liver disease should consult their doctor before taking it. Caution is necessary while driving or operating machinery, as this medication may increase the risk of hypoglycemia. Pregnant women or nursing mothers are advised to avoid taking this medication, and it should be discontinued immediately if pregnancy is confirmed. Additionally, the safety and efficacy of this medication have not been established in children under 18 years of age. There have been no reported special toxicities in the case of overdose, however, if overdose occurs, immediate medical attention should be sought for appropriate treatment. This medication must be stored out of reach of children, and it is crucial to avoid transferring it to other containers to maintain safety and quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This way, the effectiveness and safety of the medication can be preserved for a longer period.
Light yellow, biconvex, oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 2L-Proline 37.766mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Empagliflozin 2L-Proline 15.107mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Empagliflozin 2L-Proline 15.11mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Empagliflozin 2L-Proline 37.77mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Empagliflozin 2L-Proline 15.12mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Empagliflozin 2L-Proline 37.8mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.